Autologous mesenchymal stromal cell therapy (Emory University)

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameAutologous mesenchymal stromal cell therapy (Emory University)

Drug Alias Name自体间充质细胞疗法MSCs (Emory University)

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsGraft vs Host DiseaseOsteogenesis Imperfecta

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesEmory University

China Registration ClassN/A

Develop Information

Active CompaniesEmory University

Inactive CompaniesN/A

Active IndicationsOsteogenesis Imperfecta

Inactive IndicationsGraft vs Host Disease

Other Information

ATC CodeN/A